Factors predicting bacterial involvement in severe acute exacerbations of chronic obstructive pulmonary disease

Respiration

Volumn 76, Issue 3, 2008, Pages 253-260

  Nseir, Saad ^a,b   Cavestri, Béatrice ^a   Di Pompeo, Christophe ^b   Diarra, Maimouna ^a   Brisson, Hélène ^a   Lemyze, Malcolm ^a   Roussel Delvallez, Micheline ^a   Durocher, Alain ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b France Institut Pasteur de Lille   (France)

Author keywords

Acute exacerbation; Antibiotic treatment; Bacterial infection; Chronic obstructive pulmonary disease; Intensive care

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; GRAM STAINING; HAEMOPHILUS INFLUENZAE; HOSPITAL ADMISSION; HUMAN; HYPERTHERMIA; INTENSIVE CARE UNIT; INTUBATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; STREPTOCOCCUS PNEUMONIAE; SUPPURATION; TRACHEAL ASPIRATION PROCEDURE;

ACUTE DISEASE; AGED; ALGORITHMS; BRONCHOALVEOLAR LAVAGE FLUID; CALCITONIN; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INTENSIVE CARE UNITS; INTUBATION, INTRATRACHEAL; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION, ARTIFICIAL; SENSITIVITY AND SPECIFICITY;

EID: 53149154873     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000139611     Document Type: Article

References (38)

1. Rivera-Fernandez R, Navarrete-Navarro P, Fernandez-Mondejar E, et al: Six-year mortality and quality of life in critically ill patients with chronic obstructive pulmonary disease. Crit Care Med 2006;34:2317-2324.
2. Anzueto A, Sethi S, Martinez FJ: Exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007;4:554-564.
3. van Eeden SF, Sin DD: Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease. Respiration 2008;75:224-238.
4. Almagro P, Barreiro B, Ochoa DE, et al: Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease. Respiration 2006;73:311-317.
5. Pauwels RA, Rabe KF: Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004;364:613-620.
6. Esteban A, Anzueto A, Frutos F, et al: Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. JAMA 2002;287:345-355.
7. Ferrer M, Ioanas M, Arancibia F, et al: Microbial airway colonization is associated with noninvasive ventilation failure in exacerbation of chronic obstructive pulmonary disease. Crit Care Med 2005;33:2003-2009.
8. Nseir S, Di Pompeo C, Cavestri B, et al: Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: prevalence, risk factors, and outcome. Crit Care Med 2006;34:2959-2966.
9. Nouira S, Marghli S, Belghith M, et al: Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial. Lancet 2001;358:2020-2025.
10. Ewig S, Soler N, Gonzalez J, et al: Evaluation of antimicrobial treatment in mechanically ventilated patients with severe chronic obstructive pulmonary disease exacerbations. Crit Care Med 2000;28:692-697.
11. Woodhead M, Blasi F, Ewig S, et al: Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005;26:1138-1180.
12. Ram FS, Rodriguez-Roisin R, Granados-Navarrete A, et al: Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006, CD004403.
13. Cameron RJ, de Wit D, Welsh TN, et al: Virus infection in exacerbations of chronic obstructive pulmonary disease requiring ventilation. Intensive Care Med 2006;32:1022-1029.
14. Nseir S, Di Pompeo C, Soubrier S, et al: First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit. Crit Care Med 2005;33:283-289.
15. Nseir S, Di Pompeo C, Brisson H, et al: Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome. Crit Care 2006;10:R143.
16. Singh N, Rogers P, Atwood CW, et al: Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000;162:505-511.
17. Kollef MH, Micek ST: Strategies to prevent antimicrobial resistance in the intensive care unit. Crit Care Med 2005;33:1845-1853.
18. Harbarth S, Holeckova K, Froidevaux C, et al: Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001;164:396-402.
19. Uzzan B, Cohen R, Nicolas P, et al: Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006;34:1996-2003.
20. Sponholz C, Sakr Y, Reinhart K, et al: Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit Care 2006;10:R145.
21. Polzin A, Pletz M, Erbes R, et al: Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis. Eur Respir J 2003;21:939-943.
22. Stolz D, Christ-Crain M, Bingisser R, et al: Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 2007;131:9-19.
23. Marquette CH, Georges H, Wallet F, et al: Diagnostic efficiency of endotracheal aspirates with quantitative bacterial cultures in intubated patients with suspected pneumonia. Comparison with the protected specimen brush. Am Rev Respir Dis 1993;148:138-144.
24. Celli BR, MacNee W: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-946.
25. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. http://www.goldcopd.com (accessed 4 April, 2007).
26. van der Valk P, Monninkhof E, van der Palen J, et al: Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease. Clin Infect Dis 2004;39:980-986.
27. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al: Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004;363:600-607.
28. Boussekey N, Leroy O, Georges H, et al: Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit. Infection 2005;33:257-263.
29. Muller B, Harbarth S, Stolz D, et al: Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis 2007;7:10.
30. Gaini S, Koldkjaer OG, Pedersen C, et al: Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. Crit Care 2006;10:R53.
31. Roche N, Kouassi B, Rabbat A, et al: Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum. Respiration 2007;74:19-25.
32. Blot F, Raynard B, Chachaty E, et al: Value of gram stain examination of lower respiratory tract secretions for early diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med 2000;162:1731-1737.
33. Kopelman TR: Can empiric broad-spectrum antibiotics for ventilator-associated pneumonia be narrowed based on Gram's stain results of bronchoalveolar lavage fluid. Am J Surg 2006;192:812-816.
34. Stockley RA, O'Brien C, Pye A, et al: Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest 2000;117:1638-1645.
35. Soler N, Agusti C, Angrill J, et al: Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease. Thorax 2007;62:29-35.
36. Ewig S, Schlochtermeier M, Goke N, et al: Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions. Chest 2002;121:1486-1492.
37. Wilkinson TM, Patel IS, Wilks M, et al: Airway bacterial load and FEV 1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:1090-1095.
38. Nseir S, Marquette CH: Diagnosis of hospital-acquired pneumonia: postmortem studies. Infect Dis Clin North Am 2003;17:707-716.